Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jusgo is a brand of analgesic and anti-inflammatory products developed and marketed by Indi Pharma. The Jusgo product range includes oral tablets, capsules, topical gels, and sprays formulated with various combinations of active ingredients to manage pain, swelling, and inflammation. Key formulations include Jusgo Tablets (combining the NSAID aceclofenac with the analgesic paracetamol), Jusgo MR Tablets (adding the muscle relaxant chlorzoxazone), Jusgo Pan Capsules (combining aceclofenac with the proton pump inhibitor pantoprazole for gastroprotection), and topical Jusgo Gel and Spray (containing diclofenac, methyl salicylate, menthol, and linseed oil). These products are primarily indicated for the short-term relief of acute musculoskeletal pain, joint pain, and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, sprains, and strains.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jusgo.